Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7316362

Concept 2024-03-01 to
2024-05-31
As at
2024-05-31
2023-03-01 to
2024-02-29
As at
2024-02-29
As at
2023-05-31
2023-03-01 to
2023-05-31
Key financial data of reporting company
Business results of reporting company
Net sales
35,810,000,000 JPY
141,706,000,000 JPY
32,096,000,000 JPY
Ordinary profit (loss)
5,562,000,000 JPY
19,649,000,000 JPY
5,713,000,000 JPY
Net assets
266,863,000,000 JPY
267,082,000,000 JPY
261,629,000,000 JPY
Total assets
338,839,000,000 JPY
328,779,000,000 JPY
320,184,000,000 JPY
Basic earnings (loss) per share
63.89
181.62
52.09
Diluted earnings per share
63.82
181.42
52.05
Equity-to-asset ratio
0.780 xbrli:pure
0.805 xbrli:pure
0.809 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.